NHS Digital. Statistics on obesity, physical activity and diet, England, 2019. 2019. https://digital.nhs.uk/data-and-information/publications/statistical/statistics-on-obesity-physical-activity-and-diet/statistics-on-obesity-physical-activity-and-diet-england-2019/final-page. Accessed 13 May 2020.
NHS Digital. Health survey for England - 2013. 2014. https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/health-survey-for-england-2013. Accessed 13 May 2020.
Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 2016;388(10046):776–86.
Department of Health (DoH). Healthy lives, healthy people: a call to action on obesity in England. 2011. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/216096/dh_127424.pdf.
National Institute for Health and Care Excellence, (NICE). Obesity: identification, assessment and management. Clinical Guideline CG189. NICE 2014. https://www.nice.org.uk/guidance/cg189. Accessed April 2018.
•• Avenell A, Robertson C, Skea Z, Jacobsen E, Boyers D, Cooper D, et al. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technol Assess. 2018. This is the only study evaluating multiple WMPs and bariatric surgery with a lifetime horizon for costs and outcomes. Bariatric surgery was found to be the most cost-effective intervention but if surgery was not an option, a low cost short-term WMP (called WMP1) would be the most cost-effective intervention.
Jacobsen E, Boyers D, Avenell A. Challenges of systematic reviews of economic evaluations: a review of recent reviews and an obesity case study. Pharmacoeconomics. 2020;38(3):259–67.
Article PubMed PubMed Central Google Scholar
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313(7052):275–83.
Article CAS PubMed PubMed Central Google Scholar
Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004;8(36):iii–158.
Article CAS PubMed Google Scholar
Finkelstein EA, Verghese NR. Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies. Clin Obes. 2019;9(2): e12294.
Finkelstein EA, Kruger E. Meta-and cost-effectiveness analysis of commercial weight loss strategies. Obesity. 2014;22(9):1942–51.
Daumit GL, Janssen EM, Jerome GJ, Dalcin AT, Charleston J, Clark JM, et al. Cost of behavioral weight loss programs implemented in clinical practice: the POWER trial at Johns Hopkins. Transl Behav Med. 2020;10(1):103–13.
Delahanty LM, Levy DE, Chang Y, Porneala BC, Goldman V, McCarthy J, et al. Effectiveness of lifestyle intervention for type 2 diabetes in primary care: the real HEALTH-Diabetes randomized clinical trial. J Gen Intern Med. 2020;35(9):2637–46.
Article PubMed PubMed Central Google Scholar
Little P, Stuart B, Hobbs FR, Kelly J, Smith ER, Bradbury KJ, et al. Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR (Positive Online Weight Reduction). Health Technol Assess. 2017;21(4):1–62.
Article PubMed PubMed Central Google Scholar
McKnight T, Demuth JR, Wilson N, Leider JP, Knudson A. Assessing effectiveness and cost-benefit of the Trinity Hospital Twin City Fit for Life program for weight loss and diabetes prevention in a rural Midwestern town. Prev Chronic Dis. 2018;15:E98.
Article PubMed PubMed Central Google Scholar
McRobbie H, Hajek P, Peerbux S, Kahan BC, Eldridge S, Trépel D, et al. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme-a randomised controlled trial and economic evaluation. Health Technol Assess. 2016;20(79):1–149.
Article PubMed PubMed Central Google Scholar
Meenan RT, Stumbo SP, Yarborough MT, Leo MC, Yarborough BJH, Green CA. An economic evaluation of a weight loss intervention program for people with serious mental illnesses taking antipsychotic medications. Adm Policy Ment Health Ment Health Serv Res. 2016;43(4):604–15.
Patel N, Beeken RJ, Leurent B, Omar RZ, Nazareth I, Morris S. Cost-effectiveness of habit-based advice for weight control versus usual care in general practice in the Ten Top Tips (10TT) trial: economic evaluation based on a randomised controlled trial. BMJ Open. 2018;8(8): e017511.
Article PubMed PubMed Central Google Scholar
Perri MG, Limacher MC, von Castel-Roberts K, Daniels MJ, Durning PE, Janicke DM, et al. Comparative effectiveness of three doses of weight-loss counseling: two-year findings from the rural LITE trial. Obesity. 2014;22(11):2293–300.
Rhodes EC, Chandrasekar EK, Patel SA, Narayan KV, Joshua TV, Williams LB, et al. Cost-effectiveness of a faith-based lifestyle intervention for diabetes prevention among African Americans: a within-trial analysis. Diabetes Res Clin Pract. 2018;146:85–92.
Article PubMed PubMed Central Google Scholar
Tsai AG, Glick HA, Shera D, Stern L, Samaha FF. Cost-effectiveness of a low-carbohydrate diet and a standard diet in severe obesity. Obes Res. 2005;13(10):1834–40.
Article CAS PubMed Google Scholar
Tsai AG, Wadden TA, Volger S, Sarwer DB, Vetter M, Kumanyika S, et al. Cost-effectiveness of a primary care intervention to treat obesity. Int J Obes. 2013;37(1):S31–7.
•• Zhang P, Atkinson KM, Bray GA, Chen H, Clark JM, Coday M, et al. Within-trial cost-effectiveness of a structured lifestyle intervention in adults with overweight/obesity and type 2 diabetes: results from the Action for Health in Diabetes (Look AHEAD) Study. Diabetes Care. 2021;44(1):67–74. A large randomised controlled trial of a lifestyle WMP (called Look AHEAD) with 9-year follow-up, the longest trial duration that currently exists for WMPs with an economic evaluation. The comparator was standard diabetes support and education. A within-trial economic evaluation was conducted and the cost-effectiveness of the Look AHEAD intervention vs comparator was unclear.
• Gray CM, Wyke S, Zhang R, Anderson AS, Barry S, Brennan G, et al. Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study. Public Health Res. 2018;6(9):1–114. This study is a 3.5-year follow-up of an older UK randomised controlled trial published in one of the economic evaluations included in the review (Wyke et al. 2015). This is also one of the most recent model-based economic evaluations with a lifetime horizon for costs and outcomes. The updated cost-effectiveness results showed that the WMP delivered in a football club for men remained cost-effective compared to being given a booklet on losing weight.
Wyke S, Hunt K, Gray C, Fenwick E, Bunn C, Donnan P, et al. Football fans in training (FFIT): a randomised controlled trial of a gender-sensitised weight loss and healthy living programme for men. Public Health Res. 2015;3(2):1–129.
• Kent S, Aveyard P, Astbury N, Mihaylova B, Jebb SA. Is doctor referral to a low‐energy total diet replacement program cost‐effective for the routine treatment of obesity? Obesity. 2019;27(3):391–8. This is one of the most recent model-based economic evaluations with a lifetime horizon for costs and outcomes. The UK randomised controlled trial evaluating a VLCD (DROPLET trial) offered in primary care was found to be cost-effective compared to nurse-led support.
Lewis L, Taylor M, Broom J, Johnston KL. The cost-effectiveness of the LighterLife weight management programme as an intervention for obesity in England. Clin Obes. 2014;4(3):180–8.
Article CAS PubMed Google Scholar
Meads DM, Hulme CT, Hall P, Hill AJ. The cost-effectiveness of primary care referral to a UK commercial weight loss programme. Clin Obes. 2014;4(6):324–32.
Nuijten M, Marczewska A, Araujo Torres K, Rasouli B, Perugini M. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States. J Med Econ. 2018;21(9):835–44.
Radcliff TA, Côté MJ, Whittington MD, Daniels MJ, Bobroff LB, Janicke DM, et al. Cost-effectiveness of three doses of a behavioral intervention to prevent or delay type 2 diabetes in rural areas. J Acad Nutr Diet. 2020;120(7):1163–71.
Thomas C, Sadler S, Breeze P, Squires H, Gillett M, Brennan A. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open. 2017;7(8): e014953.
Article PubMed PubMed Central Google Scholar
Counterweight Project Team, Trueman P, Haynes SM, Felicity Lyons G, Louise McCombie E, McQuigg M, et al. Long-term cost-effectiveness of weight management in primary care. Int J Clin Pract. 2010;64(6):775–83.
Hollenbeak CS, Weinstock RS, Cibula D, Delahanty LM, Trief PM. Cost-effectiveness of SHINE: a telephone translation of the Diabetes Prevention Program. Health Serv Insights. 2016;9:HSI-S39084.
Ritzwoller DP, Glasgow RE, Sukhanova AY, Bennett GG, Warner ET, Greaney ML, et al. Economic analyses of the Be Fit Be Well program: a weight loss program for community health centers. J Gen Intern Med. 2013;28(12):1581–8.
Article PubMed PubMed Central Google Scholar
Krukowski RA, Tilford JM, Harvey-Berino J, West DS. Comparing behavioral weight loss modalities: incremental cost-effectiveness of an internet-based versus an in-person condition. Obesity. 2011;19(8):1629–35.
Miners A, Harris J, Felix L, Murray E, Michie S, Edwards P. An economic evaluation of adaptive e-learning devices to promote weight loss via dietary change for people with obesity. BMC Health Serv Res. 2012;12(1):190.
Article PubMed PubMed Central Google Scholar
Veerman JL, Barendregt JJ, Forster M, Vos T. Cost-effectiveness of pharmacotherapy to reduce obesity. PLoS One. 2011;6(10):e26051.
Article CAS PubMed PubMed Central Google Scholar
Hertzman P. The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden. Pharmacoeconomics. 2005;23(10):1007–20.
Article CAS PubMed Google Scholar
Lacey LA, Wolf A, O’shea D, Erny S, Ruof J. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland. Int J Obes. 2005;29(8):975–82.
Wilson KJ, Brown HS III, Bastida E. Cost-effectiveness of a community-based weight control intervention targeting a low-socioeconomic-status Mexican-origin population. Health Promot Pract. 2015;16(1):101–8.
AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.
Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, Palmer AJ. Bariatric surgery is a cost-saving treatment for obesity–a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery. Obes Rev. 2020;21(1): e12932.
Campbell JA, Venn A, Neil A, Hensher M, Sharman M, Palmer AJ. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review. Obes Rev. 2016;17(9):850–94.
留言 (0)